Related Experiment Video
Updated: Jan 12, 2026

Construction and Implantation of a Microinfusion System for Sustained Delivery of Neuroactive Agents.
Published on: March 17, 2008
Elastomeric Pumps for Continuous Subcutaneous Infusion of Symptom Control Medication on Discharge
Stephanie Gover1, Chiara Creed1, Shumi Tattersfield1
1Palliative Care and Symptom Control Team, University College London Hospitals NHS Foundation Trust (S.G., C.C., S.T., D.H., J.N.), London, United Kingdom.
Background:
Maintaining continuous subcutaneous infusion (CSCI) of symptom control medication is difficult when discharging palliative and end of life (EoL) patients.
Objectives:
To determine the feasibility of using a single use elastomeric pump (EP) to deliver CSCI medication for 24 hours, as an alternative to syringe drivers (SDs) at discharge.
Methods:
Palliative care inpatients on CSCIs leaving a tertiary hospital were prescribed an EP for day leave or discharge. We collected retrospective data over 12 months on the number of EPs administered, drug prescription, and adverse events. Hospital savings in terms of bed-days and loss of hospital pumps were extrapolated from this.
Results:
A total of 107 EPs were administered to patients leaving hospital without issue. 16 patients were given 2 EPs to facilitate administration of incompatible drugs. Extrapolated costs indicate £59,060 was saved over 12-months.
Conclusions:
EPs are a safe, effective, and cost-saving method to deliver CSCI medication for palliative care and EoL patients leaving hospital.
Related Concept Videos
Drug Accumulation During Multiple Dosing: Intermittent IV Infusions
Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy
Continuous Renal Replacement Therapy
Drug Delivery: Miscellaneous Routes
Oral inhalation and nasal sprays swiftly transfer drugs across the respiratory epithelium's mucosal layer. Inhaled glucocorticoids and bronchodilators directly target lung conditions such as asthma, while fluticasone nasal spray mitigates allergic rhinitis.
Transdermal patches transport drugs...
Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations
Peritoneal Dialysis II: Peritoneal Dialysis Systems and Complications

